當(dāng)前位置：首頁(yè) SCI期刊 SCIE期刊醫(yī)學(xué) 中科院4區(qū) JCRQ2 期刊介紹(非官網(wǎng))

International Journal Of Clinical PharmacySCIE

國(guó)際簡(jiǎn)稱：INT J CLIN PHARM-NET 參考譯名：國(guó)際臨床藥學(xué)雜志

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q2

基本信息：: ISSN：2210-7703; E-ISSN：2210-7711; 是否OA：未開(kāi)放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：NETHERLANDS; 出版商：Springer International Publishing; 出版語(yǔ)言：English; 出版周期：6 issues per year; 出版年份：1979; 研究方向：PHARMACOLOGY & PHARMACY

評(píng)價(jià)信息：: 影響因子：2.6; H-index：52; CiteScore指數(shù)：4.1; SJR指數(shù)：0.577; SNIP指數(shù)：0.86

發(fā)文數(shù)據(jù)：: Gold OA文章占比：40.62%; 研究類文章占比：75.20%; 年發(fā)文量：125; 自引率：0.0833...; 開(kāi)源占比：0.2402; 出版撤稿占比：0; 出版國(guó)人文章占比：0.03; OA被引用占比：0.1894...

投稿咨詢加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介International Journal Of Clinical Pharmacy期刊介紹

The International Journal of Clinical Pharmacy (IJCP) offers a platform for articles on research in Clinical Pharmacy, Pharmaceutical Care and related practice-oriented subjects in the pharmaceutical sciences.

IJCP is a bi-monthly, international, peer-reviewed journal that publishes original research data, new ideas and discussions on pharmacotherapy and outcome research, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics, the clinical use of medicines, medical devices and laboratory tests, information on medicines and medical devices information, pharmacy services research, medication management, other clinical aspects of pharmacy.

IJCP publishes original Research articles, Review articles , Short research reports, Commentaries, book reviews, and Letters to the Editor.

International Journal of Clinical Pharmacy is affiliated with the European Society of Clinical Pharmacy (ESCP). ESCP promotes practice and research in Clinical Pharmacy, especially in Europe. The general aim of the society is to advance education, practice and research in Clinical Pharmacy .

Until 2010 the journal was called Pharmacy World & Science.

期刊簡(jiǎn)介International Journal Of Clinical Pharmacy期刊介紹

《International Journal Of Clinical Pharmacy》自1979出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：偏慢,4-8周
醫(yī)學(xué)
PHARMACOLOGY & PHARMACY
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）International Journal Of Clinical Pharmacy Cite Score數(shù)據(jù)

CiteScore：4.1
SJR：0.577
SNIP：0.86

學(xué)科類別	分區(qū)	排名	百分位
大類：Health Professions 小類：Pharmacy	Q1	5 / 45	90%
大類：Health Professions 小類：Pharmacology (medical)	Q2	123 / 272	54%
大類：Health Professions 小類：Pharmaceutical Science	Q2	83 / 183	54%
大類：Health Professions 小類：Pharmacology	Q3	173 / 313	44%
大類：Health Professions 小類：Toxicology	Q3	80 / 133	40%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)International Journal Of Clinical Pharmacy 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	PHARMACOLOGY & PHARMACY 藥學(xué)	3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開(kāi)始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)International Journal Of Clinical Pharmacy JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	173 / 354	51.3%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q3	207 / 354	41.67%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
Spain202
France177
Netherlands125
USA92
Australia86
Turkey85
England82
GERMANY (FED REP GER)72
Portugal66
Belgium62

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Clinical effects of remimazolam alone or in combination with dexmedetomidine in patients receiving bronchoscopy and influences on postoperative cognitive function: a randomized-controlled trial
Author: Gao, Shenqiang; Wang, Tingting; Cao, Li; Li, Linyan; Yang, Shengqiang

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023; Vol. 45, Issue 1, pp. 137-145. DOI: 10.1007/s11096-022-01487-4
2、Direct-acting antiviral agent use and gastrointestinal safety in patients with chronic hepatitis C: a pharmacovigilance study based on FDA Adverse Event Reporting System
Author: Xie, Wenhuo; Zhu, Xinyan; Wang, Linyao; Li, Jianbin; Zhou, Yu

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023; Vol. 45, Issue 1, pp. 154-162. DOI: 10.1007/s11096-022-01510-8
3、Correlation between the prognostic nutritional index and outcomes in older patients aged >= 60 years with chronic heart failure
Author: Zhuang, Chenlin; Chen, Yudai; Ruan, Junshan; Yu, Huizhen; Zhu, Pengli; Zhu, YiZhun

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023; Vol. 45, Issue 1, pp. 163-173. DOI: 10.1007/s11096-022-01501-9
4、Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study
Author: Yan, Yi-Dan; Fu, Jie; Gu, Zhi-Chun; Lu, Jin-Song; Su, Ying-Jie; Lin, Hou-Wen

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023; Vol. 45, Issue 1, pp. 184-190. DOI: 10.1007/s11096-022-01450-3
5、The efficacy and safety of fluoxetine versus placebo for stroke recovery: a meta-analysis of randomized controlled trials
Author: Wu, Jixiang; Qin, Guoyong

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11096-023-01573-1
6、The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study
Author: Yao, Yao; Li, Xiaoye; Wang, Zi; Xu, Shikun; Lv, Qianzhou

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11096-022-01525-1
7、Efficacy and safety of ciprofol versus propofol for the induction of anesthesia in adult patients: a multicenter phase 2a clinical trial
Author: Zhu, Qianmei; Luo, Zhen; Wang, Xia; Wang, Dongxin; Li, Jun; Wei, Xinchuan; Tang, Jun; Yao, Shanglong; Ouyang, Wen; Zhang, Wensheng; Zuo, Yunxia; Wang, Xiao; Liu, Jin

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11096-022-01529-x
8、Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma
Author: Xu, Kai; Wu, Hong; Zhou, Chongchong; Bao, Yuwen; Yu, Min; Zhang, Lingli; Li, Xin

Journal: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11096-023-01540-w